Receptor Status Change From Primary to Residual Breast Cancer After Neoadjuvant Chemotherapy and Analysis of Survival Outcomes

摘要

After evaluating the frequency of receptor change from pretreatment to residual breast cancer after neoadjuvant chemotherapy (NCT) and their correlation with outcomes, we found that 40.7% of patients had a change in at least 1 of the receptors and that any receptor change was associated with better outcomes.